Glaxo set for big push into emerging markets

GlaxoSmithKline's new chief executive signalled his intent to launch an expansion drive into the emerging markets yesterday as he revealed his strategic objectives for the first time and announced a "transformational" partnership with a South African drugs company.

Andrew Witty, who took over from Jean-Pierre Garnier at the end of May, also admitted that the pharmaceuticals industry faced a "challenging" future as companies are set to lose billions from expired patents and the costs of research and development continue to soar. He issued a rallying cry that the industry should "seize the initiative".

Glaxo has signed a licensing and supply agreement with Aspen, a South African pharmaceuticals group, and its joint venture partner Strides Arcolab – a deal it described as "a transformational agreement to significantly extend its pharmaceutical portfolio in emerging markets".

The group added: "This signals a significant new strategy from GlaxoSmithKline to accelerate sales growth in emerging markets." Emerging markets are forecast to grow by three times the rate of the West, and will account for 40 per cent of growth in global pharmaceutical market by 2020, Glaxo added.

One of Mr Witty's first moves as chief executive was to create a new emerging markets division and appoint Abbas Hussain as president last month.

The group added it had already prioritised investments in the regions and had bulked up its regulatory expertise as a result. Speaking on the day of his first quarterly results presentation, Mr Witty said the announcement demonstrated the company's focus "where growth in both population and economic prosperity is leading to increased demand for branded pharmaceuticals".

Mr Witty also laid out his strategic priorities for Glaxo's business to investors yesterday. He plans to simplify the group's operating structure, diversify the business and put more emphasis on "products of value".

He said: "In the next few years the pharmaceutical industry will face immense challenges as an unprecedented number of products lose patent protection. This will be set against a backdrop of payers searching for ever more cost-effective healthcare and escalating patient demand for new and better medicines."

One analyst said companies would lose $200bn (£100bn) from patent expiry over the next five years and only half of that would be replaced by drugs coming through the current clinical pipeline. Mr Witty said the future of healthcare was "challenging" but held "significant opportunity".

The group is set to target growing areas including vaccines and consumer healthcare products as well as new growth areas such as biopharmaceuticals. "These businesses offer significant growth opportunities to GlaxoSmithKline through new products and geographic expansion," Mr Witty said.

James Millett, an analyst at Cazenove, said: "The strategic review from the new chief executive should give some comfort to GlaxoSmithKline investors." However, he added that there was a "lack of well-defined targets being disclosed".

Glaxo yesterday beat analyst expectations as it announced that turnover in the second quarter was up 4 per cent to £5.8bn driven by stronger performance in the vaccines division.

Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

Is this the future of flying: battery-powered planes made of plastic, and without flight decks?

Is this the future of flying?

Battery-powered planes made of plastic, and without flight decks
Isis are barbarians – but the Caliphate is a dream at the heart of all Muslim traditions

Isis are barbarians

but the Caliphate is an ancient Muslim ideal
The Brink's-Mat curse strikes again: three tons of stolen gold that brought only grief

Curse of Brink's Mat strikes again

Death of John 'Goldfinger' Palmer the latest killing related to 1983 heist
Greece debt crisis: 'The ministers talk to us about miracles' – why Greeks are cynical ahead of the bailout referendum

'The ministers talk to us about miracles'

Why Greeks are cynical ahead of the bailout referendum
Call of the wild: How science is learning to decode the way animals communicate

Call of the wild

How science is learning to decode the way animals communicate
Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test